AVXL
Price
$3.81
Change
-$0.07 (-1.80%)
Updated
May 10, 6:59 PM EST
88 days until earnings call
NGM
Price
$1.54
Change
-$0.00 (-0.00%)
Updated
Apr 4, 6:59 PM EST
81 days until earnings call
Ad is loading...

AVXL vs NGM

Header iconAVXL vs NGM Comparison
Open Charts AVXL vs NGMBanner chart's image
Anavex Life Sciences
Price$3.81
Change-$0.07 (-1.80%)
Volume$547.13K
CapitalizationN/A
NGM Biopharmaceuticals
Price$1.54
Change-$0.00 (-0.00%)
Volume$1.39M
CapitalizationN/A
View a ticker or compare two or three
AVXL vs NGM Comparison Chart

Loading...

AVXLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
AVXL vs. NGM commentary
May 13, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AVXL is a Hold and NGM is a Hold.

COMPARISON
Comparison
May 13, 2024
Stock price -- (AVXL: $3.81 vs. NGM: $1.54)
Brand notoriety: AVXL and NGM are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AVXL: 68% vs. NGM: 131%
Market capitalization -- AVXL: $322.48M vs. NGM: $128.53M
AVXL [@Biotechnology] is valued at $322.48M. NGM’s [@Biotechnology] market capitalization is $128.53M. The market cap for tickers in the [@Biotechnology] industry ranges from $568.62B to $0. The average market capitalization across the [@Biotechnology] industry is $2.65B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AVXL’s FA Score shows that 1 FA rating(s) are green whileNGM’s FA Score has 1 green FA rating(s).

  • AVXL’s FA Score: 1 green, 4 red.
  • NGM’s FA Score: 1 green, 4 red.
According to our system of comparison, NGM is a better buy in the long-term than AVXL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AVXL’s TA Score shows that 5 TA indicator(s) are bullish.

  • AVXL’s TA Score: 5 bullish, 3 bearish.

Price Growth

AVXL (@Biotechnology) experienced а -1.04% price change this week, while NGM (@Biotechnology) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.77%. For the same industry, the average monthly price growth was -5.00%, and the average quarterly price growth was +67.78%.

Reported Earning Dates

AVXL is expected to report earnings on Aug 08, 2024.

NGM is expected to report earnings on Aug 01, 2024.

Industries' Descriptions

@Biotechnology (-1.77% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for AVXL with price predictions.
OPEN
A.I.dvisor published
a Summary for NGM with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
AVXL($322M) has a higher market cap than NGM($129M). NGM YTD gains are higher at: 79.278 vs. AVXL (-59.076).
AVXLNGMAVXL / NGM
Capitalization322M129M250%
EBITDAN/AN/A-
Gain YTD-59.07679.278-75%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
AVXL: Fundamental Ratings
AVXL
OUTLOOK RATING
1..100
4
VALUATION
overvalued / fair valued / undervalued
1..100
32
Undervalued
PROFIT vs RISK RATING
1..100
93
SMR RATING
1..100
96
PRICE GROWTH RATING
1..100
89
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AVXL
RSI
ODDS (%)
Bullish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
73%
Momentum
ODDS (%)
Bullish Trend 3 days ago
76%
MACD
ODDS (%)
Bullish Trend 3 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
83%
Advances
ODDS (%)
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
79%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
82%
Aroon
ODDS (%)
Bearish Trend 3 days ago
83%
View a ticker or compare two or three
Ad is loading...
AVXLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GGHPX7.280.02
+0.28%
Goldman Sachs Intl Eq Div & Prem P
NEQIX11.840.02
+0.17%
Neuberger Berman U.S. Equity Impact I
SCMGX30.08-0.02
-0.07%
Sands Capital Global Growth Inst
FRURX21.55-0.02
-0.09%
Franklin Utilities R
IENIX32.25-0.18
-0.56%
Invesco Energy R5